Cross Examination of Atenolol and Canderstan Cilexetil on the Treatment of Hypertension

Mingxuan Yang

2022

Abstract

Hypertension is a serious medical condition that has led to approximately a total of 7.6 million deaths annually throughout the globe. In retrospect of the entire medical history, many drugs had been used for the treatment of hypertension, but none had presented a consummate solution that could eradicate or prevent hypertension previously at all. Nowadays, with the fast-developing medical industries, people can gain access to more medications targeting hypertension with a far wider range of scope and through more convenient facilitations. Drugs such as atenolol and canderstan cilexetil had furthermore also became some of the most popular drugs used to treat high blood pressure with the precondition of a prospering modern medical market. In order to resolve one of the most difficult medical problems that hovered through the entire human history until now, it is essentially necessary to understand what is the best equipment that can defeat the abhorrent enemy in the entire medical field----hypertension.

Paper Citation

in Harvard Style

Yang M. (2022). Cross Examination of Atenolol and Canderstan Cilexetil on the Treatment of Hypertension. In Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB, ISBN 978-989-758-595-1, pages 1153-1163. DOI: 10.5220/0011381300003443

in Bibtex Style

@conference{icbeb22,
author={Mingxuan Yang},
title={Cross Examination of Atenolol and Canderstan Cilexetil on the Treatment of Hypertension},
booktitle={Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB,},
year={2022},
pages={1153-1163},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0011381300003443},
isbn={978-989-758-595-1},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB,
TI - Cross Examination of Atenolol and Canderstan Cilexetil on the Treatment of Hypertension
SN - 978-989-758-595-1
AU - Yang M.
PY - 2022
SP - 1153
EP - 1163
DO - 10.5220/0011381300003443